Net Income Loss

Name: ArriVent BioPharma, Inc. Net Income Loss by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

ArriVent BioPharma, Inc.·Business Segments·1 segment·Rolls up to Net Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Business Segments	-$64.39M	-$31.4M	-$34.98M	-$35.54M	-$43.32M
Total	-$64.39M	-$31.4M	-$34.98M	-$35.54M	-$43.32M

Business SegmentsView metric